These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31785356)

  • 1. The Influence of Metoclopramide on Trigeminovascular Nociception: Possible Anti-migraine Mechanism of Action.
    Dolgorukova A; Osipchuk AV; Murzina AA; Sokolov AY
    Neuroscience; 2020 Jan; 425():123-133. PubMed ID: 31785356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the central projection of the dural trigeminovascular system for migraine prophylaxis.
    Akerman S; Romero-Reyes M
    J Cereb Blood Flow Metab; 2019 Apr; 39(4):704-717. PubMed ID: 28885085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal PAC1 receptors mediate delayed activation and sensitization of trigeminocervical neurons: Relevance to migraine.
    Akerman S; Goadsby PJ
    Sci Transl Med; 2015 Oct; 7(308):308ra157. PubMed ID: 26446954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for orexinergic mechanisms in migraine.
    Hoffmann J; Supronsinchai W; Akerman S; Andreou AP; Winrow CJ; Renger J; Hargreaves R; Goadsby PJ
    Neurobiol Dis; 2015 Feb; 74():137-43. PubMed ID: 25447225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of nociceptive dural input to the trigeminocervical complex through oxytocinergic transmission.
    García-Boll E; Martínez-Lorenzana G; Condés-Lara M; González-Hernández A
    Exp Neurol; 2020 Jan; 323():113079. PubMed ID: 31678349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of 5-HT3 receptors with granisetron does not affect trigeminothalamic nociceptive transmission in rats: Implication for migraine.
    Sokolov AY; Sivachenko IB; Panteleev SS; Lyubashina OA
    Clin Exp Pharmacol Physiol; 2018 Jan; 45(1):34-41. PubMed ID: 28853174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents.
    Akerman S; Holland PR; Lasalandra MP; Goadsby PJ
    Headache; 2009 Sep; 49(8):1131-43. PubMed ID: 19719541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of nociceptive dural input to the trigeminocervical complex through GluK1 kainate receptors.
    Andreou AP; Holland PR; Lasalandra MP; Goadsby PJ
    Pain; 2015 Mar; 156(3):439-450. PubMed ID: 25679470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraine.
    Oliveira MM; Akerman S; Tavares I; Goadsby PJ
    Pain; 2016 Aug; 157(8):1666-1673. PubMed ID: 27023421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pearls and pitfalls in experimental in vivo models of migraine: dural trigeminovascular nociception.
    Akerman S; Holland PR; Hoffmann J
    Cephalalgia; 2013 Jun; 33(8):577-92. PubMed ID: 23671254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception.
    Holland PR; Akerman S; Goadsby PJ
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1380-5. PubMed ID: 16160082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metoclopramide inhibits trigeminovascular activation:evidence for effective acute attack treatment in migraine.
    Doğanay Aydin H; Vuralli D; Akçali DT; Bolay H
    Turk J Med Sci; 2017 Feb; 47(1):343-347. PubMed ID: 28263512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonergic mechanisms of trigeminal meningeal nociception: Implications for migraine pain.
    Kilinc E; Guerrero-Toro C; Zakharov A; Vitale C; Gubert-Olive M; Koroleva K; Timonina A; Luz LL; Shelukhina I; Giniatullina R; Tore F; Safronov BV; Giniatullin R
    Neuropharmacology; 2017 Apr; 116():160-173. PubMed ID: 28025094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate inhibits trigeminovascular activation: an intravital microscopy study.
    Akerman S; Goadsby PJ
    Br J Pharmacol; 2005 Sep; 146(1):7-14. PubMed ID: 15980877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of Nav1.8 currents in nociceptive trigeminal neurons contributes to anti-trigeminovascular nociceptive effect of amitriptyline.
    Liang J; Liu X; Pan M; Dai W; Dong Z; Wang X; Liu R; Zheng J; Yu S
    Neuromolecular Med; 2014 Jun; 16(2):308-21. PubMed ID: 24292897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous dextromethorphan/quinidine inhibits activity of dura-sensitive spinal trigeminal neurons in rats.
    Sokolov AY; Lyubashina OA; Berkovich RR; Panteleev SS
    Eur J Pain; 2015 Sep; 19(8):1086-94. PubMed ID: 25410439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway.
    Andreou AP; Goadsby PJ
    Cephalalgia; 2011 Oct; 31(13):1343-58. PubMed ID: 21893557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: a Fos protein study.
    Park J; Moon H; Akerman S; Holland PR; Lasalandra MP; Andreou AP; Ferrari MD; van den Maagdenberg AM; Goadsby PJ
    Neurobiol Dis; 2014 Apr; 64():1-7. PubMed ID: 24355314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGRP and the Trigeminal System in Migraine.
    Iyengar S; Johnson KW; Ossipov MH; Aurora SK
    Headache; 2019 May; 59(5):659-681. PubMed ID: 30982963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the pharmacological targeting of the trigeminocervical complex in the context of treatments of migraine.
    Akerman S; Romero-Reyes M
    Expert Rev Neurother; 2013 Sep; 13(9):1041-59. PubMed ID: 23952299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.